Home
Conditions
Multiple Myeloma

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

2,608 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Not Yet Recruiting

Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma

NCT07614360

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma

NCT07247097

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

NCT07660939

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

PET-Enabled Dual-Energy CT in Multiple Myeloma

NCT07646873

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: UC Davis EXPLORER Molecular Imaging Center Sacramento, California, United States

View Trial Details

Not Yet Recruiting

A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma

NCT07612787

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Centre Hospitalier Universitaire Amiens, France

Centre Hospitalier Universitaire Angers, France

Centre Hospitalier Universitaire Annecy, France

Centre Hospitalier D'Argenteuil Argenteuil, France

View all 30 locations

View Trial Details

Not Yet Recruiting

CM336-SOC for Dynamically High-Risk Multiple Myeloma Study

NCT07648459

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma

NCT07628595

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study

NCT07634263

Conditions: Behavior, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations: Copenhagen University Hospital (Rigshospitalet) Copenhagen, Denmark

Odense University Hospital Odense, Denmark

Sjællands Universitets Hospital Roskilde, Denmark

View Trial Details

Not Yet Recruiting

Self-administered Subcutaneous Daratumumab in Patients With Multiple Myeloma

NCT07191379

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

NCT04579523

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Multiple Myeloma

Multiple Myeloma trial results

Related conditions